Helixgate https://validator.w3.org/feed/docs/rss2.html Opinion: The unintended consequences of the Lindsay Clancy case Genetic Toolkit Isolates Neuron Types in Drosophila Brain Molecular Pathways Driving Autoantibody Production Following SARS-CoV-2 Infection Identified BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines ‘Worse than expected’ Wainua data muddies water for TTR silencers BioXcel files for bankruptcy, will sell assets to Teva for up to $125M Generate Bio drops as data accidentally leaked ahead of European conference AstraZeneca, Ionis data spark debate about RNA drugs’ impact on deadly heart disease Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio Priovant nabs first FDA approval for targeted tablet in dermatomyositis AstraZeneca, Amgen poised to challenge Dupixent’s reign with esophagitis win Multispecifics are transforming the CDMO development architecture CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own Megascale microbiome analysis with DartUniFrac Ancient Peptides Resurrected from Lactoferrin’s Evolutionary Past Could Point to New Antibiotics STAT+: FDA approves Roivant therapy for rare autoimmune disease UCSF QBI Awarded $46M to Translate Landmark Autism Map Into Precision Therapies STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns Kennedy posts vaccine misinformation, spars on social media amid measles deaths Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage STAT+: Former Stanford president releases emails to rebut fraud and cover-up allegations in new book Fragile X at a turning point: Breaking through the clinical bottleneck Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA 324-million-year-old fossil reveals how insects conquered land Nearly 1/4 dealing with long-term unemployment call it quits on biopharma job searches The great disconnect: 4 ways companies, job candidates misalign CAR Ts will only treat autoimmune diseases if we can scale delivery Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerate Juul gets OK to sell updated vaping device with age-gating technology Spyre tumbles as immune drug misses mark in rheumatoid arthritis RevMed receives early FDA approval for ‘groundbreaking’ pancreatic cancer drug Research into protein interactions sheds new light on causes of autism Summit, Akeso tout biliary cancer win for PD-1/VEGF in China—but details are pending Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company. BMS ends Cellares pact over cell therapy production problems, triggering layoffs Biohaven could get up to $795M in epilepsy alliance with SK Bio 2026 IPO stock tracker: How newly public biotechs are performing Jazz scores front-line gastric cancer nod from FDA for ‘practice-changing’ Ziihera Weight-loss pill may quiet alcohol cravings RevMed could become ‘next oncology titan’ with Rasonque nod Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealed CDMO hiring tough as demand for specialized talent outpaces supply AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh Automated prototyping of genetic codes Home